Press Releases

Keyword Search

News Category Financial

Year None20212020201920182017201620152014

Date	Title
01/31/21	MediciNova Announces Closing of US$20 Million Private Placement Transaction
01/18/21	MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan
01/11/21	MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners